Funding

Tissium

France · Healthtech · Biotech · Enterprise software

Develops biomorphic programmable polymers that repair nerves and tissue without stitches

Visit tissium.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series D+€30MCathay — Role not disclosedMérieux Développement — Role not disclosed

Investors

CathaySeries D+Mérieux DéveloppementSeries D+

Coverage

Jun 24, 2026Tissium · Series D+

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Sourcestissium.com ↗